Clorox has finalized a $2.25 billion acquisition of GOJO Industries, enhancing its health and hygiene portfolio despite facing mixed financial results. The company reported second-quarter revenue of $1.67 billion, exceeding expectations, but adjusted earnings of $1.39 per share fell short, contributing to ongoing pressures from ERP system implementation and increased marketing costs. Clorox's stock has surged 24.91% year-to-date, reflecting investor confidence, even as challenges persist in sustaining profit margins and managing elevated promotional expenses.